食管腺癌放化疗后延迟与及时食管切除术的结局比较
基于美国国家癌症数据库2004至2014年数据,纳入8489例临床II/III期食管腺癌接受术前放化疗后手术的患者,比较及时手术(<90天,n=7822)与延迟手术(≥90天,n=667)的结局。多因素分析显示延迟手术并非总生存下降的独立相关因素。
要点
- 延迟食管切除术组90天死亡率高于及时手术组(10.4% vs 7.8%)。
- 延迟组病理完全缓解率高于及时组(22.2% vs 18.6%)。
- 多因素分析显示延迟手术未独立降低总生存。
核心结论
- 尽管围手术期死亡率增加,延迟和挽救性食管切除术似乎与及时食管切除术具有相似的长期生存。
研究设计与样本
- 回顾性数据库研究,查询美国国家癌症数据库2004至2014年数据,纳入8489例临床II或III期食管腺癌接受术前放化疗和食管切除术的患者。
主要发现
- 多因素分析显示延迟食管切除术并非总生存下降的独立相关因素。
关键数值与推荐
- 及时食管切除术组为放化疗后<90天手术(n=7822),延迟食管切除术组为≥90天手术(n=667)。
- 及时组放化疗后中位间隔为49天(范围40-61天),延迟组为109天(范围97-132天)。
临床怎么用
- 对于放化疗后未及时接受食管切除术的患者,可考虑提供延迟和挽救性食管切除术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Salvage and delayed esophagectomy after chemoradiation therapy (CRT) have been associated with increased morbidity and mortality, but recent series have shown similar outcomes compared to timely esophagectomy. We aim to evaluate outcomes for delayed and salvage esophagectomy for esophageal adenocarcinoma utilizing a large national database. METHODS: The National Cancer Database for 2004 to 2014 was queried for patients with clinical stage II or III esophageal adenocarcinoma who underwent preoperative CRT and esophagectomy. Patients who underwent surgery <90 days after CRT were defined as the timely esophagectomy group (n = 7822), and those who underwent surgery ≥90 days after CRT were defined as the delayed esophagectomy group (n = 667). RESULTS: A total of 8489 patients met our inclusion criteria. The median post-CRT interval was 49 days (range, 40-61 days) for the timely esophagectomy group and 109 days (range, 97-132 days) for the delayed esophagectomy group. The delayed group was more likely to be of black race (2.3% vs 1.2%; P < .01) and more likely to have Medicare (47.9% vs 39.8%; P < .001). There were no significant between-group differences in chemotherapy regimens (P = .17), radiation dose (P = .18), or surgical approach (P = .48). The delayed esophagectomy group had higher rates of pathological complete response (22.2% vs 18.6%; P = .043) and 90-day postoperative mortality (10.4% vs 7.8%; P < .01). On multivariate analysis, delayed esophagectomy was not independently associated with decreased overall survival. CONCLUSIONS: In this large retrospective database study, despite increased perioperative mortality, delayed and salvage esophagectomy for adenocarcinoma appear to have similar long-term survival as timely esophagectomy. Delayed and salvage esophagectomy may be offered to patients who do not receive timely esophagectomy after CRT.
引用
- Levinsky NC, Wima K, Morris MC, et al. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019. PMID: 31767364. doi:10.1016/j.jtcvs.2019.09.169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。